Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


Articles published in Pulm Pharmacol Ther

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    November 2024
  1. D B, I A, I B, A B, et al
    Triple inhaled therapy in asthma: beliefs, behaviours and doubts.
    Pulm Pharmacol Ther. 2024 Nov 19:102333. doi: 10.1016/j.pupt.2024.102333.
    PubMed     Abstract available


    October 2024
  2. SHI H, Chen Z, Lei Q, Ma D, et al
    Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma.
    Pulm Pharmacol Ther. 2024;87:102329.
    PubMed     Abstract available


    December 2023
  3. WANG J, Jian Q, Yan K, Yang J, et al
    m(6)A-modified miR-143-3p inhibits epithelial mesenchymal transition in bronchial epithelial cells and extracellular matrix production in lung fibroblasts by targeting Smad3.
    Pulm Pharmacol Ther. 2023;83:102251.
    PubMed     Abstract available


    November 2023
  4. DEBOWSKI T, Marko M, Rogala B, Majak P, et al
    Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy - control study.
    Pulm Pharmacol Ther. 2023 Nov 28:102272. doi: 10.1016/j.pupt.2023.102272.
    PubMed     Abstract available


  5. DRAGONIERI S, Quaranta VN, Portacci A, Carpagnano GE, et al
    Can single-inhaler Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium therapy postpone or save biologics for severe asthma?
    Pulm Pharmacol Ther. 2023;83:102270.
    PubMed     Abstract available


    October 2023
  6. ROGLIANI P, Radovanovic D, Ora J, Starc N, et al
    Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol.
    Pulm Pharmacol Ther. 2023;82:102231.
    PubMed     Abstract available


    April 2023
  7. TAKEDA Y, Takahashi M, Fuchikami JI, Nakamura H, et al
    Effect of roflumilast on airway remodeling in asthmatic mice exposed to or not exposed to cigarette smoke: Comparison with the effect of dexamethasone.
    Pulm Pharmacol Ther. 2023;79:102198.
    PubMed     Abstract available


    January 2023
  8. ZHANG P, Jia Y, Jing Z, Huang J, et al
    Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma.
    Pulm Pharmacol Ther. 2023 Jan 2:102187. doi: 10.1016/j.pupt.2022.102187.
    PubMed     Abstract available


    December 2022
  9. MA S, Yang K, Li Z, Li L, et al
    A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells.
    Pulm Pharmacol Ther. 2022;78:102185.
    PubMed     Abstract available


  10. O'BYRNE PM, Panettieri RA Jr, Taube C, Brindicci C, et al
    Development of an inhaled anti-TSLP therapy for asthma.
    Pulm Pharmacol Ther. 2022;78:102184.
    PubMed     Abstract available


  11. XU J, Yang L, Lin T
    beta-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthma.
    Pulm Pharmacol Ther. 2022 Dec 5:102183. doi: 10.1016/j.pupt.2022.102183.
    PubMed     Abstract available


  12. DAVIS BE, Cockcroft DW
    Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics.
    Pulm Pharmacol Ther. 2022;77:102174.
    PubMed     Abstract available


  13. BRATTSAND R, Selroos O
    May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?
    Pulm Pharmacol Ther. 2022;77:102167.
    PubMed     Abstract available


    October 2022
  14. GUO YL, Chen ZC, Li N, Tian CJ, et al
    SRSF1 promotes ASMC proliferation in asthma by competitively binding CCND2 with miRNA-135a.
    Pulm Pharmacol Ther. 2022 Oct 21:102173. doi: 10.1016/j.pupt.2022.102173.
    PubMed     Abstract available


    August 2022
  15. CHEN H, Kunder R, Zou Y, Staton T, et al
    Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation.
    Pulm Pharmacol Ther. 2022;75:102133.
    PubMed     Abstract available


    July 2022
  16. TSUBOKAWA D, Satoh M
    Strongyloides venezuelensis-derived venestatin ameliorates asthma pathogenesis by suppressing receptor for advanced glycation end-products-mediated signaling.
    Pulm Pharmacol Ther. 2022 Jul 18:102148. doi: 10.1016/j.pupt.2022.102148.
    PubMed     Abstract available


    June 2022
  17. NAGASE H, Tamaoki J, Suzuki T, Nezu Y, et al
    Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan.
    Pulm Pharmacol Ther. 2022 Jun 14:102130. doi: 10.1016/j.pupt.2022.102130.
    PubMed     Abstract available


    April 2022
  18. BUHL R, Nikolaev I, Tillmann HC, Vaidya S, et al
    Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021)
    Pulm Pharmacol Ther. 2022 Apr 11:102126. doi: 10.1016/j.pupt.2022.102126.
    PubMed    


    March 2022
  19. CALZETTA L, Pistocchini E, Cito G, Ritondo BL, et al
    Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma.
    Pulm Pharmacol Ther. 2022 Mar 26:102125. doi: 10.1016/j.pupt.2022.102125.
    PubMed     Abstract available


    December 2021
  20. ZORAMPARI C, Prakash A, Rehan HS, Gupta LK, et al
    Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma.
    Pulm Pharmacol Ther. 2021 Dec 31:102109. doi: 10.1016/j.pupt.2021.102109.
    PubMed    


  21. ZHU R, Owen R, Wilkins J, Schoemaker R, et al
    Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps.
    Pulm Pharmacol Ther. 2021;71:102080.
    PubMed     Abstract available


  22. ROSSI V, Salimaki J, Sandler C, Airaksinen M, et al
    Effectiveness of inhalation technique assessment service for patients with Respimat(R) inhaler.
    Pulm Pharmacol Ther. 2021;71:102077.
    PubMed     Abstract available


    October 2021
  23. SUTTON SS, Magagnoli J, Cummings TH, Hardin JW, et al
    Leukotriene Inhibition and the Risk of Lung Cancer among U.S. Veterans with Asthma.
    Pulm Pharmacol Ther. 2021 Oct 15:102084. doi: 10.1016/j.pupt.2021.102084.
    PubMed     Abstract available


  24. ALIDA B, Stefania P, Noemi CM, Maria I, et al
    Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: tips for facing the second wave.
    Pulm Pharmacol Ther. 2021 Oct 7:102083. doi: 10.1016/j.pupt.2021.102083.
    PubMed     Abstract available


  25. VAIDYA S, Ziegler D, Tanase AM, Malmqvist U, et al
    Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
    Pulm Pharmacol Ther. 2021;70:102019.
    PubMed     Abstract available


    August 2021
  26. LUO Y, Chen H, Huang R, Wu Q, et al
    Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-kappaB signals in OVA-induced asthmatic mice.
    Pulm Pharmacol Ther. 2021;69:102049.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.